Impaired fibrinolysis in sickle cell disease. Relation to crisis and infection.
D000755:Anemia, Sickle Cell / Q000097:blood* / Q000150:complications; D000933:Antifibrinolytic Agents / Q000097:blood; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D004789:Enzyme Activation; D005169:Factor VIII / Q000032:analysis; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D005342:Fibrinolysis; D006505:Hepatitis / Q000150:complications; D006801:Humans; D007239:Infections / Q000150:complications; D010958:Plasminogen / Q000032:analysis; D011014:Pneumonia / Q000150:complications; D011704:Pyelonephritis / Q000150:complications; D018805:Sepsis / Q000150:complications
D000933:Antifibrinolytic Agents; D005169:Factor VIII; D010958:Plasminogen; D005341:Fibrinolysin